$CNC

Centene reported a 14-cent-per-share loss, but adjusted per-share earnings were 58 cents.

Centene reported a GAAP loss of $0.14 per share but adjusted earnings of $0.58 per share for Q3 2026. Revenues rose 0.5% to $45.1 billion, driven by Medicare and Medicaid growth. The company improved its 2026 EPS guidance and reduced debt by $1.1 billion. Membership declined in Medicaid and Marketplace but grew in Medicare.

Original reporting
Published Oct 27, 2026, 10:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 10:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CNC
Bearish
high confidence
Mentioned
$CNC
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CNCBearishHigh
01

Why it matters

The mixed earnings signal may cause short‑term volatility but suggest underlying operational improvements.

02

Market read

Centene's earnings are a key driver for the health‑care sector and can influence investor sentiment toward similar insurers.

03

What to watch

Improved health‑benefits ratio and Medicaid growth may offset the GAAP loss over the longer term.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Centene is a major U.S. managed‑care insurer; its quarterly results are closely watched for Medicaid and Medicare trends.

Company-level read

Ticker impact

$CNCBearishHigh confidence
Context

Centene reported a GAAP loss of $0.14 per share and adjusted EPS of $0.58 for Q3 2026, updating its 2026 guidance.

Expected impact

likely pressure as investors price in the GAAP loss despite adjusted earnings beat

Evidence & confidence

Earnings surprise on the loss side is material for a large‑cap health insurer; market typically reacts quickly to GAAP miss.

Market effects

May weigh on other managed‑care insurers as GAAP earnings pressure spreads.

U.S. health‑care sector could see modest pullback in early trading.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

Adjusted EPS beat could support a bounce if the market focuses on underlying profitability.

Key entities

  • Centene Corp

    U.S. health insurer reporting Q3 2026 results.

Related articles

$CNCMedAI 8/10

What Centene (CNC) Said on Its Q3 Earnings Call

Centene (CNC) reported Q3 earnings, highlighting strong Medicare segment performance with a 93.8% HBR. The company raised its 2026 pre-tax margin forecast for PDP to mid-to-high 3% and expects Medicare Advantage break-even in 2026. Marketplace margins are improving, with a full-year 2026 pre-tax margin expected at the top of the 4.5%-5% range. Centene reduced debt to $15.0B and expects adjusted EPS growth in 2027.

$CNCHighAI 8/10

Centene (CNC) Q3 2026 Earnings Call Transcript

Centene (CNC) reported Q3 2026 earnings, highlighting a Medicaid HBR of 93.6, up 30 basis points from Q2. The company expects full-year Medicaid HBR of 93.5. Medicaid membership was in line with expectations, with a projected 8-9% year-end decline. Medicare Advantage and standalone Part D performed well, with Medicare Advantage on track for 2026 breakeven. Marketplace business is expected to produce a full-year pretax margin at the top of the 4.5% to 5.0% range.

$CNCMed

Centene Corporation Q3 2026 Earnings Call Summary

Centene Corporation reported Q3 2026 earnings, highlighting Medicare Advantage breakeven, Medicaid stability, and Marketplace margin recovery. The company reduced debt to $15.0 billion and expects 2027 adjusted EPS growth. Management plans to exit less profitable areas and optimize costs. Medicaid membership is declining, and Marketplace enrollment may contract in 2027. Non-recurring benefits added $0.50 per share in 2026.

$CNCMed

Centene progresses on profit recovery, drops 6,000 employees

Centene reported Q3 revenue of $50.6B, up 2% YoY, and narrowed losses to $71M. The company raised its 2026 earnings outlook due to Medicare Advantage cost reductions, now expecting to break even in the segment. Centene also announced layoffs and voluntary separations, reducing its workforce by 6,000 employees, which is expected to improve margins in 2027. The company's medical loss ratio was 92.7%, slightly better than expected.